> top > docs > PMC:7274968 > spans > 3131-3341 > annotations

PMC:7274968 / 3131-3341 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T5 159-167 Body_part denotes androgen http://purl.org/sig/ont/fma/fma83375

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T31 11-12 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T32 135-137 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T33 138-140 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T34 145-146 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 159-167 Chemical denotes androgen http://purl.obolibrary.org/obo/CHEBI_50113
T3 191-194 Chemical denotes ADT http://purl.obolibrary.org/obo/CHEBI_40799

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T28 0-210 Sentence denotes The use of a neoadjuvant treatment up to an expected resolution of the peak of the pandemic was recommended by the 82% of the centers (18/22) if a concomitant androgen deprivation treatment (ADT) was indicated.